0001104659-23-080104.txt : 20230711
0001104659-23-080104.hdr.sgml : 20230711
20230711203123
ACCESSION NUMBER: 0001104659-23-080104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230707
FILED AS OF DATE: 20230711
DATE AS OF CHANGE: 20230711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BATOR MICHAEL G.
CENTRAL INDEX KEY: 0001647591
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36792
FILM NUMBER: 231083093
MAIL ADDRESS:
STREET 1: C/O CYTOSORBENTS CORP.
STREET 2: 7 DEER PARK DR., SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytosorbents Corp
CENTRAL INDEX KEY: 0001175151
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980373793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 973-329-8885
MAIL ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: MedaSorb Technologies CORP
DATE OF NAME CHANGE: 20060807
FORMER COMPANY:
FORMER CONFORMED NAME: GILDER ENTERPRISES INC
DATE OF NAME CHANGE: 20020611
4
1
tm2321021-6_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-07-07
0
0001175151
Cytosorbents Corp
CTSO
0001647591
BATOR MICHAEL G.
C/O CYTOSORBENTS CORPORATION
305 COLLEGE ROAD EAST
PRINCETON
NJ
08540
1
0
0
0
0
Common Stock
84800
D
Stock Option (right to buy)
3.53
2023-07-07
4
A
0
40000
0
A
2033-07-07
Common Stock
40000
40000
D
Includes (a) the following restricted stock units which will vest upon a "Change of Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, and (iii) 60,000 restricted stock units granted on June 7, 2016, and (b) 15,500 shares of common stock owned by the reporting person.
The stock options were granted pursuant to the Plan. The shares underlying the stock options shall vest in full on the first anniversary of the award date, subject to the reporting person's continued service as of the applicable vesting date.
/s/ Kathleen P. Bloch attorney-in-fact Michael G. Bator
2023-07-11